GeneXpert RSVRespiratory Infection Diagnosis
cepheid-logo

 

 

 

4-in-1 Real-Time PCR Respiratory Testing

Diagnose with MORE certainty. 

Xpert® Xpress CoV-2/Flu/RSV plus^ is a gold standard on-demand PCR testing solution for respiratory season.

RSV PCR Multiplex RT-PCR test - SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV)
GeneXpert RSV Accurate and timely results - results for SARS-CoV-2 in as little as 25 minutes or all four pathogens in 36 minutes*
real time pcr Optimized workflow - improved patient-flow management which leads to positive patient experience

 

Accurate Detection of Respiratory Viruses – Easy as 1, 2, 3

 

GeneXpert RSV

 

  • Minimal staff training with a simple, easy-to-use workflow and minimal hands-on time.
  • The same test can run across the healthcare continuum from the hospital lab to the point of care.
  • Multiple genetic targets, human and avian coverage, for broad-strain coverage to mitigate impact of genetic drift
  • Closed system reduces risk of contamination.

 

Be ready this respiratory season

Get MORE than results with GeneXpert® Xpress system† and Xpert® Xpress CoV-2/Flu/RSV plus^ test.
You may download the flyers below for additional information or fill out the form to connect with a Cepheid Sales Associate.

 

GeneXpert RSV Download Xpert Xpress CoV-2/Flu/RSV plus flyer
Respiratory Infection Diagnosis Download GeneXpert Xpress flyer
References

† US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries
^ In the United States, this test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
*Results in as little as 25 mins for positives when running SARS-CoV-2 only on Xpert Xpress CoV-2/Flu/RSV plus

 

Choose a real time PCR test for your patients
Connect with us today

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

.